Literature DB >> 24395128

The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels.

Masanori Yoshikawa1, Motoo Yamauchi, Yukio Fujita, Noriko Koyama, Atsuhiko Fukuoka, Shinji Tamaki, Yoshifumi Yamamoto, Koichi Tomoda, Hiroshi Kimura.   

Abstract

PURPOSE: Although obstructive sleep apnea syndrome (OSAS) is known to be an important risk factor for cardiovascular diseases, the mechanism behind this association has not been fully elucidated. Transendothelial migration of monocytes mediated by adhesion molecules is a crucial step in the pathogenesis of atherosclerosis. We investigated the effect of hypoxic stress on plasma adiponectin and tumor necrosis factor-α (TNF-α) levels and whether adiponectin and TNF-α modulate adhesion molecules in patients with OSAS.
METHODS: In 22 patients, plasma adiponectin and TNF-α levels and serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1) were determined early in the morning after polysomnography and after nasal continuous positive airway pressure (nCPAP) treatment.
RESULTS: Plasma adiponectin levels were inversely correlated with the apnea-hypopnea index (AHI) (r = -0.582, p < 0.005) and % time in SpO2 <90 % (r = -0.539, p < 0.01) but not with the body mass index (BMI). TNF-α levels were positively correlated with the AHI (r = 0.462, p < 0.05) and BMI (r = 0.452, p < 0.05). Serum sICAM-1 levels were inversely correlated with plasma adiponectin levels (r = -0.476, p < 0.05) but not with TNF-α levels. Although plasma TNF-α levels decreased after overnight nCPAP treatment (p < 0.05), plasma adiponectin levels increased after long-term nCPAP (3 months) treatment (p < 0.02) in ten patients.
CONCLUSIONS: Our findings suggest that reduced adiponectin and elevated TNF-α levels in plasma are associated with OSAS-induced hypoxic stress. Decreased adiponectin levels are associated with sICAM-1 levels.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24395128     DOI: 10.1007/s00408-013-9550-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  36 in total

1.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

2.  Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome.

Authors:  Ahmet Ursavaş; Mehmet Karadağ; Erkan Rodoplu; Arzu Yilmaztepe; Haluk Barbaros Oral; R Oktay Gözü
Journal:  Respiration       Date:  2006-12-04       Impact factor: 3.580

3.  Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

4.  Reduced levels of adiponectin in sleep apnea syndrome.

Authors:  B Masserini; P S Morpurgo; F Donadio; C Baldessari; R Bossi; P Beck-Peccoz; E Orsi
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

5.  Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome.

Authors:  E Ohga; T Nagase; T Tomita; S Teramoto; T Matsuse; H Katayama; Y Ouchi
Journal:  J Appl Physiol (1985)       Date:  1999-07

6.  Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.

Authors:  Shinya Makino; Hiroshi Handa; Koji Suzukawa; Masayoshi Fujiwara; Masaharu Nakamura; Shogo Muraoka; Ikumi Takasago; Yasushi Tanaka; Kozo Hashimoto; Tamotsu Sugimoto
Journal:  Clin Endocrinol (Oxf)       Date:  2006-01       Impact factor: 3.478

7.  Prognostic value of adiponectin for cardiovascular disease and mortality.

Authors:  Jacqueline M Dekker; Tohru Funahashi; Giel Nijpels; Stefan Pilz; Coen D A Stehouwer; Marieke B Snijder; Lex M Bouter; Yuji Matsuzawa; Iichiro Shimomura; Robert J Heine
Journal:  J Clin Endocrinol Metab       Date:  2008-01-22       Impact factor: 5.958

8.  Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnoea syndrome.

Authors:  Shinji Tamaki; Motoo Yamauchi; Atsuhiko Fukuoka; Kiyoshi Makinodan; Noriko Koyama; Koichi Tomoda; Masanori Yoshikawa; Hiroshi Kimura
Journal:  Respirology       Date:  2009-05-19       Impact factor: 6.424

9.  Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome.

Authors:  Yasuhiko Nakagawa; Ken Kishida; Shinji Kihara; Mina Sonoda; Ayumu Hirata; Atsutaka Yasui; Hitoshi Nishizawa; Tadashi Nakamura; Ryoko Yoshida; Iichiro Shimomura; Tohru Funahashi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-15       Impact factor: 4.310

10.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.

Authors:  Norikazu Maeda; Iichiro Shimomura; Ken Kishida; Hitoshi Nishizawa; Morihiro Matsuda; Hiroyuki Nagaretani; Naoki Furuyama; Hidehiko Kondo; Masahiko Takahashi; Yukio Arita; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Yoshihiro Tochino; Keiichi Okutomi; Masato Horie; Satoshi Takeda; Toshifumi Aoyama; Tohru Funahashi; Yuji Matsuzawa
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

View more
  6 in total

1.  Effects of Continuous Positive Airway Pressure on Cell Adhesion Molecules in Patients with Obstructive Sleep Apnea: A Meta-Analysis.

Authors:  Zongsheng Tian; Jinyu Xiao; Jing Kang; Hongying Sun; Zhuangzhuang Mu; Dan Tong; Mingxian Li
Journal:  Lung       Date:  2021-11-20       Impact factor: 2.584

2.  Effect of Continuous Positive Airway Pressure on Adiponectin in Patients with Obstructive Sleep Apnea: A Meta-Analysis.

Authors:  Li-Da Chen; Jian-Nan Liu; Li Lin; Zhi Wu; Hao Li; Yu-Ming Ye; Qiao-Zhen Xu; Qi-Chang Lin
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

3.  A change in objective sleep duration is associated with a change in the serum adiponectin level of women with overweight or obesity undergoing weight loss intervention.

Authors:  R Sawamoto; T Nozaki; T Furukawa; T Tanahashi; C Morita; T Hata; M Nakashima; G Komaki; N Sudo
Journal:  Obes Sci Pract       Date:  2016-03-14

4.  Targeted sequencing analysis of the adiponectin gene identifies variants associated with obstructive sleep apnoea in Chinese Han population.

Authors:  Yunyun Yang; Song Yang; Xiaolu Jiao; Juan Li; Hao Wu; Haili Sun; Yunxiao Yang; Ming Zhang; Yongxiang Wei; Yanwen Qin
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

5.  Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Ping Ma; Bradley G Phillips
Journal:  Sleep Breath       Date:  2020-10-09       Impact factor: 2.816

Review 6.  Roles and Mechanisms of Obstructive Sleep Apnea-Hypopnea Syndrome and Chronic Intermittent Hypoxia in Atherosclerosis: Evidence and Prospective.

Authors:  Linqin Ma; Jingchun Zhang; Yue Liu
Journal:  Oxid Med Cell Longev       Date:  2016-05-16       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.